Bioventus BVS International Segment — Adjusted cost of sales

Similar metrics at other companies

MLKNInternational Contract — Adjusted cost of sales

$112.5M-4.3%

UEICReportable Segment — Adjusted cost of sales

$47.32M-30.9%

JEL

JELDEurope — Adjusted cost of sales

$217.26M+9.8%

SMGHawthorne — Adjusted cost of sales

$32.4M-49.9%

TILEAMS — Adjusted cost of sales

$125.72M-6.9%

TILEEAAA — Adjusted cost of sales

$91.9M+0.8%

FAQ

What is Bioventus's international segment — adjusted cost of sales?

Bioventus (BVS) reported international segment — adjusted cost of sales of $6.68M in Q2 2026.

How has Bioventus's international segment — adjusted cost of sales changed year-over-year?

Bioventus's international segment — adjusted cost of sales decreased by 1.0% year-over-year, from $6.75M to $6.68M.

What is the long-term trend for Bioventus's international segment — adjusted cost of sales?

Over 3 years (2022 to 2025), Bioventus's international segment — adjusted cost of sales has grown at a 7.8% compound annual growth rate (CAGR), from $19.85M to $24.86M.

What does international segment — adjusted cost of sales mean?

Reflects the direct costs associated with producing and delivering products sold within the international segment, excluding non-recurring or non-operational charges. Monitoring this helps evaluate the production efficiency and supply chain cost structure specific to international operations.